Dr. Michael B. Azarkh, MD

Dr. Azarkh practices at Nazareth Hospital in Philadelphia, Pennsylvania, part of Trinity Health.

Dr. Azarkh's NPI, 1790958452, was assigned on April 2, 2008. Dr. Azarkh holds California license A116986.

Dr. Azarkh's primary practice is Nazareth Hospital, at 2601 Holme Ave, Philadelphia, PA 19152 in Philadelphia County. The practice phone is (215) 335-6000.

Dr. Azarkh's primary practice is Nazareth Hospital in Philadelphia, Pennsylvania, part of Trinity Health. Dr. Azarkh is also affiliated with Thomas Jefferson University Hospital. The medical group on file is Vituity. Dmand AI also links Dr. Azarkh to 5 more hospitals, 2 medical groups and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Azarkh practices, 8 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Azarkh's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Dr. Azarkh's licenses on file in 2 states: California and New Mexico.

CMS data shows 106 Medicare services from Dr. Azarkh across 4 procedure codes in 2024, for 66 Medicare patients. Medicare paid $10,861 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 66 Medicare patients who saw Dr. Azarkh in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 3.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Azarkh's median patient age at 62, with 48% women.

In 2024, Dr. Azarkh wrote 109 Medicare Part D claims for 24 patients. 70% of them were for generic drugs. CMS names the drug for 50 of them, across 4 drugs with 11 or more claims each, at $10,497 in total drug cost. In 2023, CMS named 119 claims across 7 drugs.

Dr. Azarkh accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 5 general payments to Dr. Azarkh from 5 drug and device companies from 2016 to 2025. Education speaker fees make up the largest share, 66% of the total. Novartis Pharmaceuticals Corporation paid the most, $150.